Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Boehringer Ingelheim
McKinsey
Medtronic
Accenture
Queensland Health
Express Scripts
Covington
Teva

Generated: June 19, 2018

DrugPatentWatch Database Preview

Iodoxamate meglumine - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for iodoxamate meglumine and what is the scope of iodoxamate meglumine freedom to operate?

Iodoxamate meglumine
is the generic ingredient in one branded drug marketed by Bracco and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

Summary for iodoxamate meglumine
US Patents:0
Tradenames:1
Applicants:1
NDAs:2
Bulk Api Vendors: 10
Clinical Trials: 33
Patent Applications: 22
DailyMed Link:iodoxamate meglumine at DailyMed
Synonyms for iodoxamate meglumine
3-[3-[2-[2-[2-[3-(3-carboxy-2,4,6-triiodoanilino)-3-oxopropo
3-[3-[2-[2-[2-[3-(3-carboxy-2,4,6-triiodoanilino)-3-oxopropoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-2,4,6-triiodobenzoic acid
3-[3-[2-[2-[2-[3-(3-carboxy-2,4,6-triiodoanilino)-3-oxopropoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-2,4,6-triiodobenzoic acid; 6-(methylamino)hexane-1,2,3,4,5-pentol
3,3'-(Ethylenebis(oxyethyleneoxyethylenecarbonylimino))bis(2,4,6-triiodobenzoic acid)
3,3'-(Ethylenebis(oxyethyleneoxyethylenecarbonylimino))bis(2,4,6-triiodobenzoic acid) compound with 1-deoxy-1-(methylamino)-D-glucitol (1:2)
31127-82-9
39472-29-2
4,7,10,13-Tetraoxahexadecane-1,16-dioyl-bis(3-carboxytriiodoanilide)
51764-33-1
AC1L1UBY
AC1L233I
Acide iodoxamique
Acide iodoxamique [INN-French]
Acido iodossamico
Acido iodossamico [DCIT]
Acido iodoxamico
Acido iodoxamico [INN-Spanish]
Acidum iodoxamicum
Acidum iodoxamicum [INN-Latin]
B 10610
B-10610
BC-17
Benzoic acid, 3,3'-((1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-diyl)diimino)bis(2,4,6-triiodo-
Benzoic acid, 3,3'-((1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-diyl)diimino)bis(2,4,6-triiodo-, compound with 1-deoxy-1-(methylamino)-D-glucitol (1:2)
Benzoic acid, 3,3'-(ethylenebis(oxyethyleneoxyethylenecarbonylimino))bis(2,4,6-triiodo-
Bis(1-deoxy-1-(methylamino)-D-glucitol) 3,3'-((1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-diyl)diimino)bis(2,4,6-triiodobenzoate)
BRN 2801368
CAS-31127-82-9
CHEBI:31707
CHEMBL1615487
Cholevue
Cholovue
Cholovue (TN)
CIX5G6J9R1
D-Glucitol, 1-deoxy-1-(methylamino)-, 3,3'-((1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-diyl)diimino)bis(2,4,6-triiodobenzoate) (2:1) (salt)
D01312
D02DJS
D04573
DR003726
DSSTox_CID_31499
DSSTox_GSID_57710
DSSTox_RID_97384
DTXSID4057710
EINECS 250-478-1
EINECS 257-398-6
Endobil
Endobil (TN)
Endomirabil
Iodoxamate meglumine (USAN)
Iodoxamate Meglumine [USAN:BAN]
Iodoxamic acid
Iodoxamic acid (JAN/USAN/INN)
Iodoxamic acid [USAN:BAN:INN:JAN]
Iodoxamic acid meglumine salt
iodoxamicacid
Iodoxamsaeure
Iodoxamsaeure [German]
LP084872
LS-37414
LS-71357
Meglumine iodoxamate
Methylglucamine iodoxamate
NCGC00262940-01
NS1Y283HW4
SCHEMBL377402
SQ 21982
SQ-21982
Tox21_113933
UNII-CIX5G6J9R1
UNII-NS1Y283HW4
Videocolangio

US Patents and Regulatory Information for iodoxamate meglumine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco CHOLOVUE iodoxamate meglumine INJECTABLE;INJECTION 018077-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bracco CHOLOVUE iodoxamate meglumine INJECTABLE;INJECTION 018076-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for iodoxamate meglumine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco CHOLOVUE iodoxamate meglumine INJECTABLE;INJECTION 018077-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Bracco CHOLOVUE iodoxamate meglumine INJECTABLE;INJECTION 018076-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Deloitte
Covington
US Department of Justice
Teva
Cipla
UBS
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.